A Single-Center Phase 2 Open-Label Trial Evaluating the Safety and Efficacy of Daratumumab in Treatment of Patients with Monoclonal Gammopathy of Renal Significance

被引：0
|
作者：
Zand, Ladan
Rajkumar, S. Vincent
Sethi, Sanjeev
Leung, Nelson
Fervenza, Fernando C.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance
    Premkumar, Vikram
    Lentzsch, Suzanne
    Bhutani, Divaya
    BLOOD, 2019, 134
  • [2] Single-center, open-label, efficacy and safety study of tazarotene for the treatment of brittle nails
    Sherber, Noelle
    Hoch, Ariel
    Coppola, Carol
    Mackay-Wiggan, Julian
    Scher, Richard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB100 - AB100
  • [3] Safety of Daiobotampito in the Treatment of Acute Diverticulitis of the Colon: A Single-Center, Open-Label, Prospective Trial
    Koike, Hiroshi
    Nakazawa, Atsushi
    Horiba, Yuko
    Tsukada, Nobuhiro
    Watanabe, Kenji
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2017, 23 (11) : 885 - 889
  • [4] Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure
    Fujisue, Koichiro
    Ito, Miwa
    Matsuzawa, Yasushi
    Arima, Yuichiro
    Takashio, Seiji
    Sueta, Daisuke
    Araki, Satoshi
    Hanatani, Shinsuke
    Yamanaga, Kenshi
    Yamamoto, Masahiro
    Kaneko, Shozo
    Yamamoto, Eiichiro
    Matsushita, Kenichi
    Soejima, Hirofumi
    Tsujita, Kenichi
    CIRCULATION REPORTS, 2024, 6 (03) : 55 - 63
  • [5] A RANDOMIZED, OPEN-LABEL, SINGLE-CENTER, PHASE II CLINICAL TRIAL TO EXPLORE THE SAFETY AND EFFICACY OF RECOMBINANT HEPATITIS B IMMUNOGLOBULIN
    Song, Gi-Won
    Lee, Sung-Gyu
    Hwang, Shin
    Park, Gil-Chun
    Chung, Yongkyu
    Ha, Su-Min
    Kang, Sang-Hyun
    Lee, Hyoung Uk
    Lee, Yun Hee
    Kwon, Jae-Hyun
    Jwa, Eun-Kyung
    Cho, Hwui-Dong
    TRANSPLANT INTERNATIONAL, 2017, 30 : 231 - 231
  • [6] Efficacy and safety of apatinib in advanced sarcoma: an open-label, nonrandomized, single-center study of 45 patients
    Yao Weitao
    Wu Fangxing
    Cai Qiqing
    Wang Jiaqiang
    ANTI-CANCER DRUGS, 2019, 30 (07) : 749 - 756
  • [7] A Single-center, Open-label, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of the Indirect Bonding Technique
    Murakami, Takashi
    Kawanabe, Noriaki
    Kataoka, Tomoki
    Hoshijima, Mitsuhiro
    Komori, Hiroki
    Fujisawa, Atsuro
    Kamioka, Hiroshi
    ACTA MEDICA OKAYAMA, 2016, 70 (05) : 413 - 416
  • [8] The efficacy and safety of chidamide in combination with etoposide and glucocorticoids for the treatment of hemophagocytic lymphohistiocytosis in adult patients: an open-label, single-center study
    Hu, Junxia
    Wang, Jingshi
    Wang, Zhao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)
    Awada, Gil
    Ben Salama, Laila
    De Cremer, Jennifer
    Schwarze, Julia Katharina
    Fischbuch, Lydia
    Seynaeve, Laura
    Du Four, Stephanie
    Vanbinst, Anne-Marie
    Michotte, Alex
    Everaert, Hendrik
    Rogiers, Anne
    Theuns, Peter
    Duerinck, Johnny
    Neyns, Bart
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [10] Open-label, single-center, safety dose escalation trial of alefacept for the treatment of moderate to severe chronic plaque psoriasis
    Moul, Danielle K.
    Routhouska, Shannon B.
    Korman, Neil J.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2007, 11 (04) : 132 - 136
12345